# Molecular You Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/molecular-you

- Industry: Healthcare
- Headquarters: Vancouver, Canada
- Website: www.molecularyou.com
- Total disclosed funding: $5M
- Latest round: Series A (Aug 20, 2025)
- Investors on record: 2

## About

Based in Canada, Molecular You Corporation focuses on transforming healthcare through advanced blood analyses, providing users with personalized insights for better health management and chronic disease prevention.Molecular You Corporation specializes in comprehensive health assessments utilizing advanced blood analysis. Founded in 2014 and headquartered in Vancouver, Canada, the company has received Series A funding totaling USD 5.00 mn led by Voloridge Health, LLC. on August 20, 2025. The company has conducted one deal to date. The founder has not been specified.Molecular You specializes in comprehensive health assessments based on advanced blood analysis, offering insights that empower individuals and healthcare providers to make informed health decisions. Their primary product is a testing service that initiates with a blood sample collected in a clinical setting, which is then sent to their labs for thorough evaluation of over 250 blood-based biomarkers. The resulting personalized reports provide tailored recommendations for diet, lifestyle, and treatment strategies aimed at addressing high-risk health areas and managing chronic conditions. This service is designed for both individual consumers seeking to optimize their health and healthcare providers aiming to enhance patient care. The company caters to markets primarily in North America and Europe, targeting both healthcare professionals and individual patients who are proactive about their health management.Molecular You generates revenue through a direct-to-consumer business model alongside partnerships with healthcare providers. The core revenue stream derives from the sale of health assessment tests, which are structured around a per-test pricing framework, allowing clients to purchase evaluations as needed. In addition to individual testing, the company engages in subscription services for ongoing health monitoring and follow-up assessments, providing continual value through updated reports reflecting the latest scientific findings. The transactional nature of the business emphasizes accessibility and convenience, enabling patients and providers to order tests and receive actionable health insights efficiently. Specific pricing details for these flagship services are integral to the company's commercial strategy, underpinning its commitment to delivering personalized health insights.In August 2025, Molecular You Corporation raised USD 5.00 mn in Series A funding led by new investor Voloridge Health, LLC., with participation from another new investor Dynamic Leap. The funding will be utilized to grow its customer base across consumer and clinical channels in North America and expand its platform's analysis and predictive capabilities. The company is also planning to launch new products aimed at enhancing its health assessment services, targeting additional markets in North America and Europe by the end of 2026.

## Funding rounds

- Series A, Aug 20, 2025, $5M — Voloridge Health, LLC., Dynamic Leap

## Investors

- Voloridge Health, LLC. — Series A
- Dynamic Leap (https://capitalatlas.ai/funds/dynamic-leap) — Series A